Nodule Solitary Pulmonary clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Biomarkers for Risk Stratification in Lung Cancer
open to eligible people ages 40 years and up
This is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of two primary populations to determine the ctDNA assay performance in a variety of clinical settings.
San Francisco, California and other locations
Our lead scientists for Nodule Solitary Pulmonary research studies include Mehrdad Arjomandi, M.D..